IP Library Granted Patent US 7,238,501
Granted Patent B2
US 7,238,501 · App. 10/610,561 · Granted Jul 3, 2007

Process for producing trans-4-hydroxy-L-proline

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,238,501
App. No.
10/610,561
Granted
Jul 3, 2007
Kind
B2
Abstract

The present invention is directed to a process for producing trans-4-hydroxy-L-proline, which is useful as a raw material for medicines or as an additive to foods. In the process, L-proline is converted into trans-4-hydroxy-L-proline in the presence of an enzyme source which is derived from a microorganism belonging to the genus Dactylosporangium, Amycolatopsis or Streptomyces and which catalyzes the hydroxylation of L-proline into trans-4-hydroxy-L-proline, a divalent iron ion and 2-ketoglutaric acid, in an aqueous medium, and the produced trans-4-hydroxy-L-proline is collected from the aqueous medium. In addition, the present invention is directed to a process for producing trans-4-hydroxy-L-proline, wherein the L-proline biosynthesis activity of the host cell of the transformant is reinforced.

Claims (30)

1. A method for producing trans-4-hydroxy-L-proline, which comprises:

(a) cultivating in a medium a transformant obtained by introducing into host cell selected from the group consisting of microorganism and isolated animal cell a recombinant DNA comprising a DNA coding for L-proline-4-hydroxylase,

wherein the DNA is a DNA having any one of nucleotide sequences of SEQ ID NO: 3, 9, and 16, or is a DNA hybridizing to the DNA having any one of nucleotide sequences of SEQ ID NO: 3, 9 and 16 in a solution comprising 50% (v/v) formadide, 2% blocking reagent, 0.1% (w/v) N-laurylsarcosine, 0.02% (w/v) SDS, 750 mM sodium chloride and 75 mM sodium citrate at 42° C. for 1 hour,

wherein the hybridizing comprises additional steps of: washing twice in a solution containing 0.1% SDS, 300 mM sodium chloride and 30 mM sodium citrate at room temperature for 5 minutes, and washing twice with a solution comprising 0.1% SDS, 15 mM sodium chloride and 1.5 mM sodium citrate at 68° C. for 15 minutes each;

(b) producing and accumulating trans-4-hydroxy-L-proline; and

(c) collecting the trans-4-hydroxy-L-proline from the resulting culture.

2. The method for producing trans-4-hydroxy-L-proline according to claim 1 , wherein L-proline is added to the medium.

3. The method for producing trans-4-hydroxy-L-proline according to claim 1 , wherein L-proline, 2-ketoglutaric acid and divalent iron ions are added to the medium.

4. The method for producing trans-4-hydroxy-L-proline according to claim 1 , wherein the DNA codes for a protein having any one of amino acid sequences of SEQ ID NO: 2,19 and 20.

5. The method for producing trans-4-hydroxy-L-proline according to claim 1 , wherein the DNA is derived from a microorganism belonging to a genus selected from the group consisting of Dactylosporangium, Amycolatopsis and Streptomyces.

6. The method for producing trans-4-hydroxy-L-proline according to claim 1 , wherein the DNA is derived from a microorganism selected from the group consisting of Dactylosporangium sp. RH1 (FERM BP-4400), Amycolatopsis sp. RH2 (FERM BP-4581), Streptomyces griseoviridis JCM4250 and Streptomyces daghestanicus JCM4365.

7. The method of claim 1 , wherein the host cell is further transformed with the proA or proB genes from E. coli.

8. The method of claim 1 , wherein the host cell is further transformed with the proA or proB74 genes from E. coli.

9. A method for producing trans-4-hydroxy-L-proline, which comprises:

(a) adding to an aqueous medium

(i) cells of a transformant isolated from a culture of the transformant obtained by introducing into a host cell selected from the group consisting of microorganism and isolated animal cell a recombinant DNA comprising a DNA coding for L-proline-4-hydroxylase,

(ii) L-proline,

(iii) a divalent iron ion, and

(iv) 2-ketoglutaric acid,

wherein the DNA is a DNA having any one of nucleotide sequences of SEQ ID NO: 3, 9 and 16, or is a DNA hybridizing to the DNA having any one of nucleotide sequences of SEQ ID NO: 3, 9 and 16 in a solution comprising 50% (v/v) formamide, 2% blocking reagent, 0.1% (w/v) N-laurylsarcosine, 0.02% (w/v) SDS, 750 mM sodium chloride and 75 mM sodium citrate at 42° C. for 1 hour;

wherein the hybridizing comprises additional steps of: washing twice in a solution containing 0.1% SDS, 300 mM sodium chloride and 30 mM sodium citrate at room temperature for 5 minutes, and washing twice with a solution containing 0.1% SDS, 15 mM sodium chloride and 1.5 mM sodium citrate at 68° C. for 15 minute each,

(b) converting L-proline into trans-4-hydroxy-Lproline; and

(c) collecting the resulting trans-4-hydroxy-L-proline from the aqueous medium.

10. The method for producing trans-4-hydroxy-L-proline according to claim 9 , wherein the cells are immobilized cells.

11. The method for producing trans-4-hydroxy-L-proline according to claim 9 , wherein the DNA codes for a protein having any one of amino acid sequences of SEQ ID NO: 2, 19 and 20.

12. The method for producing trans-4-hydroxy-L-proline according to claim 9 , wherein the DNA is derived from a microorganism belonging to a genus selected from the group consisting of Dactylosporangium, Amycolatopsis and Streptomyces.

13. The method for producing trans-4-hydroxy-L-proline according to claim 9 , wherein the DNA is derived from the group consisting of Dactylosporangium sp. RH1 (FERM BP-4400), Amycolatopsis sp. RH2 (FERM BP-4581), Streptomyces griseoviridis JCM4250 and Streptomyces daghestanicus JCM4365.

14. The method of claim 9 , wherein the host cell is further transformed with the proA or proB genes from E. coli.

15. The method of claim 9 , wherein the host cell is further transformed with the proA and proB74 genes from E. coli .

16. The method for producing trans-4-hydroxyl-L-proline according to claim 5 , wherein the microorganisms are selected from those of Dactylosporangium sp. RH1 (FERM BP-4400), Amycolatopsis sp. RH2 (FERM BP-4581), Streptomyces griseoviridis JCM4250 and Streptomyces daghestanicus JCM4365.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 022399/0602 →